NY A 9211
in committeeRelates to newborn screening for Gaucher disease
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 9211 pass?
Not yet. NY A 9211 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH
What is NY A 9211 about?
Requires that newborns are tested for Gaucher disease.
Who sponsors NY A 9211?
Alex Bores is the primary sponsor of NY A 9211, joined by 6 cosponsors.
Description
Requires that newborns are tested for Gaucher disease.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- Alex Boresprimary
- MaryJane Shimskycosponsor
- Robert C. Carrollcosponsor
- Phil Steckcosponsor
- Rebecca Seawrightcosponsor
- Joe DeStefanocosponsor
- Edward Braunsteincosponsor
Committees
Not provided by source.
Action timeline
2025-11-03
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- A9211Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 8545
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 9211. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.